Research
Molecular
Several biomarkers reflecting various pathophysiological pathways linking obesity and cardiometabolic diseases have been identified.
Practitioners should consider these biomarkers in understanding obesity-related health risks.
StrongSupportsmedium confidence
Several biomarkers that may reflect various pathophysiological pathways that link obesity and cardiometabolic diseases have been identified over the past decades.
Why this rating
The claim is based on a summary of research evidence.
Source
Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk
Krasimira Aleksandrova et al. · Clinical Chemistry · 2017
DOI 10.1373/clinchem.2017.275172
reviewCited 81×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →